Centessa Pharmaceuticals (NASDAQ:CNTA) Coverage Initiated at Needham & Company LLC
Stock analysts at Needham & Company LLC assumed coverage on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) in a note issued to investors on Wednesday, MarketBeat reports. The brokerage set a “buy” rating and a $35.00 price target on the stock. Needham & Company LLC’s price objective indicates a potential upside of 167.79% […]
